{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T12:32:14Z","timestamp":1786710734795,"version":"build-2736575974"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Deanship of Research and Graduate Studies at King Khalid University","award":["RGP2\/639\/46"],"award-info":[{"award-number":["RGP2\/639\/46"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12544-w","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T11:42:02Z","timestamp":1786707722000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Phage and CRISPR based precision antimicrobials: a dual strategy against multidrug-resistant bacteria"],"prefix":"10.1007","volume":"53","author":[{"given":"Anjaneyulu","family":"Musini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod Kumar","family":"Yata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5693-2953","authenticated-orcid":false,"given":"Sarad Pawar Naik","family":"Bukke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalal","family":"Akhila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teetla","family":"Shivani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bayapa Reddy","family":"Narapureddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandrashekar","family":"Thalluri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Awad Osman Abdalla","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Dhawelbate Mohammed","family":"Adam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"issue":"3","key":"12544_CR1","doi-asserted-by":"publisher","first-page":"442","DOI":"10.55519\/JAMC-03-9395","volume":"34","author":"F Adnan","year":"2022","unstructured":"Adnan F, Khursheed N, Khan M, Ali MM, Hussain S, Mansoor N (2022) Changing Trends Of Multidrug Resistant Bacteria: A Six Year Experience From A Tertiary Care Hospital. J Ayub Med Coll Abbottabad: JAMC 34(3):442\u2013446. https:\/\/doi.org\/10.55519\/JAMC-03-9395","journal-title":"J Ayub Med Coll Abbottabad: JAMC"},{"issue":"8","key":"12544_CR2","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.3390\/genes13081397","volume":"13","author":"M Rozwadowski","year":"2022","unstructured":"Rozwadowski M, Gawel D (2022) Molecular Factors and Mechanisms Driving Multidrug Resistance in Uropathogenic Escherichia coli-An Update. Genes 13(8):1397. https:\/\/doi.org\/10.3390\/genes13081397","journal-title":"Genes"},{"issue":"9","key":"12544_CR3","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.3390\/antibiotics11091215","volume":"11","author":"F Zhang","year":"2022","unstructured":"Zhang F, Cheng W (2022) The Mechanism of Bacterial Resistance and Potential Bacteriostatic Strategies. Antibiot (Basel Switzerland) 11(9):1215. https:\/\/doi.org\/10.3390\/antibiotics11091215","journal-title":"Antibiot (Basel Switzerland)"},{"issue":"1","key":"12544_CR4","doi-asserted-by":"publisher","first-page":"fuab048","DOI":"10.1093\/femsre\/fuab048","volume":"46","author":"JE Egido","year":"2022","unstructured":"Egido JE, Costa AR, Aparicio-Maldonado C, Haas PJ, Brouns SJJ (2022) Mechanisms and clinical importance of bacteriophage resistance. FEMS Microbiol Rev 46(1):fuab048. https:\/\/doi.org\/10.1093\/femsre\/fuab048","journal-title":"FEMS Microbiol Rev"},{"issue":"7","key":"12544_CR5","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.3390\/v16071000","volume":"16","author":"CJ Kovacs","year":"2024","unstructured":"Kovacs CJ, Rapp EM, Rankin WR, McKenzie SM, Brasko BK, Hebert KE, Bachert BA, Kick AR, Burpo FJ, Barnhill JC (2024) Combinations of Bacteriophage Are Efficacious against Multidrug-Resistant Pseudomonas aeruginosa and Enhance Sensitivity to Carbapenem Antibiotics. Viruses 16(7):1000. https:\/\/doi.org\/10.3390\/v16071000","journal-title":"Viruses"},{"issue":"4","key":"12544_CR6","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.13345\/j.cjb.220633","volume":"39","author":"T Hong","year":"2023","unstructured":"Hong T, Luo Q (2023) Sheng wu gong cheng xue. bao = Chin J Biotechnol 39(4):1363\u20131373. https:\/\/doi.org\/10.13345\/j.cjb.220633","journal-title":"bao = Chin J Biotechnol"},{"issue":"7","key":"12544_CR7","doi-asserted-by":"publisher","first-page":"lxad137","DOI":"10.1093\/jambio\/lxad137","volume":"134","author":"VP Shetty","year":"2023","unstructured":"Shetty VP, Akshay SD, Rai P, Deekshit VK (2023) Integrons as the potential targets for combating multidrug resistance in Enterobacteriaceae using CRISPR- Cas9 technique. J Appl Microbiol 134(7):lxad137. https:\/\/doi.org\/10.1093\/jambio\/lxad137","journal-title":"J Appl Microbiol"},{"issue":"8","key":"12544_CR8","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1007\/s12033-021-00340-9","volume":"63","author":"A Shukla","year":"2021","unstructured":"Shukla A, Jani N, Polra M, Kamath A, Patel D (2021) CRISPR: The Multidrug Resistance Endgame? Mol Biotechnol 63(8):676\u2013685. https:\/\/doi.org\/10.1007\/s12033-021-00340-9","journal-title":"Mol Biotechnol"},{"issue":"6268","key":"12544_CR9","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1126\/science.aad5227","volume":"351","author":"IM Slaymaker","year":"2016","unstructured":"Slaymaker IM, Gao L, Zetsche B, Scott DA, Yan WX, Zhang F (2016) Rationally engineered Cas9 nucleases with improved specificity. Sci (New York N Y) 351(6268):84\u201388. https:\/\/doi.org\/10.1126\/science.aad5227","journal-title":"Sci (New York N Y)"},{"key":"12544_CR10","doi-asserted-by":"publisher","unstructured":"Ranjbar R, Alam M (2023) Antimicrobial Resistance Collaborators (2022). Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Evidence-based nursing, ebnurs-2022-103540. Advance online publication. https:\/\/doi.org\/10.1136\/ebnurs-2022-103540","DOI":"10.1136\/ebnurs-2022-103540"},{"key":"12544_CR11","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.copbio.2020.11.012","volume":"68","author":"C Fage","year":"2021","unstructured":"Fage C, Lemire N, Moineau S (2021) Delivery of CRISPR-Cas systems using phage-based vectors. Curr Opin Biotechnol 68:174\u2013180. https:\/\/doi.org\/10.1016\/j.copbio.2020.11.012","journal-title":"Curr Opin Biotechnol"},{"key":"12544_CR12","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s44149-023-00065-z","volume":"3","author":"FB Balcha","year":"2023","unstructured":"Balcha FB, Neja SA (2023) CRISPR-Cas9 mediated phage therapy as an alternative to antibiotics. Anim Dis 3:4. https:\/\/doi.org\/10.1186\/s44149-023-00065-z","journal-title":"Anim Dis"},{"issue":"5","key":"12544_CR13","doi-asserted-by":"publisher","first-page":"109930","DOI":"10.1016\/j.celrep.2021.109930","volume":"37","author":"KN Lam","year":"2021","unstructured":"Lam KN, Spanogiannopoulos P, Soto-Perez P, Alexander M, Nalley MJ, Bisanz JE, Nayak RR, Weakley AM, Yu FB, Turnbaugh PJ (2021) Phage-delivered CRISPR-Cas9 for strain-specific depletion and genomic deletions in the gut microbiome. Cell Rep 37(5):109930. https:\/\/doi.org\/10.1016\/j.celrep.2021.109930","journal-title":"Cell Rep"},{"issue":"11","key":"12544_CR14","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/nbt.3011","volume":"32","author":"RJ Citorik","year":"2014","unstructured":"Citorik RJ, Mimee M, Lu TK (2014) Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases. Nat Biotechnol 32(11):1141\u20131145. https:\/\/doi.org\/10.1038\/nbt.3011","journal-title":"Nat Biotechnol"},{"issue":"23","key":"12544_CR15","doi-asserted-by":"publisher","first-page":"7267","DOI":"10.1073\/pnas.1500107112","volume":"112","author":"I Yosef","year":"2015","unstructured":"Yosef I, Manor M, Kiro R, Qimron U (2015) Temperate and lytic bacteriophages programmed to sensitize and kill antibiotic-resistant bacteria. Proc Natl Acad Sci USA 112(23):7267\u20137272. https:\/\/doi.org\/10.1073\/pnas.1500107112","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"12544_CR16","doi-asserted-by":"publisher","first-page":"106475","DOI":"10.1016\/j.ijantimicag.2021.106475","volume":"59","author":"TK Yeh","year":"2022","unstructured":"Yeh TK, Jean SS, Lee YL, Lu MC, Ko WC, Lin HJ, Liu PY, Hsueh PR (2022) Bacteriophages and phage-delivered CRISPR-Cas system as antibacterial therapy. Int J Antimicrob Agents 59(1):106475. https:\/\/doi.org\/10.1016\/j.ijantimicag.2021.106475","journal-title":"Int J Antimicrob Agents"},{"issue":"7","key":"12544_CR17","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1021\/acsinfecdis.2c00649","volume":"9","author":"A Mayorga-Ramos","year":"2023","unstructured":"Mayorga-Ramos A, Z\u00fa\u00f1iga-Miranda J, Carrera-Pacheco SE, Barba-Ostria C, Guam\u00e1n LP (2023) CRISPR-Cas-Based Antimicrobials: Design, Challenges, and Bacterial Mechanisms of Resistance. ACS Infect Dis 9(7):1283\u20131302. https:\/\/doi.org\/10.1021\/acsinfecdis.2c00649","journal-title":"ACS Infect Dis"},{"issue":"1","key":"12544_CR18","doi-asserted-by":"publisher","first-page":"lsad030","DOI":"10.1093\/jlb\/lsad030","volume":"11","author":"DM Pacia","year":"2024","unstructured":"Pacia DM, Brown BL, Minssen T, Darrow JJ (2024) CRISPR-phage antibacterials to address the antibiotic resistance crisis: scientific, economic, and regulatory considerations. J law Biosci 11(1):lsad030. https:\/\/doi.org\/10.1093\/jlb\/lsad030","journal-title":"J law Biosci"},{"key":"12544_CR19","doi-asserted-by":"publisher","unstructured":"Sun D, Jeannot K, Xiao Y, Knapp CW (2019) Editorial: Horizontal Gene Transfer Mediated Bacterial Antibiotic Resistance. Front Microbiol 10:1933. https:\/\/doi.org\/10.3389\/fmicb.2019.01933","DOI":"10.3389\/fmicb.2019.01933"},{"issue":"1","key":"12544_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40779-021-00362-z","volume":"9","author":"Z Shen","year":"2022","unstructured":"Shen Z, Tang CM, Liu GY (2022) Towards a better understanding of antimicrobial resistance dissemination: what can be learnt from studying model conjugative plasmids? Military Med Res 9(1):3. https:\/\/doi.org\/10.1186\/s40779-021-00362-z","journal-title":"Military Med Res"},{"issue":"11","key":"12544_CR21","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1038\/nbt.3043","volume":"32","author":"D Bikard","year":"2014","unstructured":"Bikard D, Euler CW, Jiang W, Nussenzweig PM, Goldberg GW, Duportet X, Fischetti VA, Marraffini LA (2014) Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials. Nat Biotechnol 32(11):1146\u20131150. https:\/\/doi.org\/10.1038\/nbt.3043","journal-title":"Nat Biotechnol"},{"issue":"6","key":"12544_CR22","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1089\/crispr.2024.0001","volume":"7","author":"A Ates","year":"2024","unstructured":"Ates A, Tastan C, Ermertcan S (2024) CRISPR-Cas9-Mediated Targeting of Multidrug Resistance Genes in Methicillin-Resistant Staphylococcus aureus. CRISPR J 7(6):374\u2013384. https:\/\/doi.org\/10.1089\/crispr.2024.0001","journal-title":"CRISPR J"},{"issue":"1","key":"12544_CR23","doi-asserted-by":"publisher","first-page":"e000324","DOI":"10.1099\/mgen.0.000324","volume":"6","author":"SG Giulieri","year":"2020","unstructured":"Giulieri SG, Tong SYC, Williamson DA (2020) Using genomics to understand meticillin- and vancomycin-resistant Staphylococcus aureusinfections. Microb genomics 6(1):e000324. https:\/\/doi.org\/10.1099\/mgen.0.000324","journal-title":"Microb genomics"},{"issue":"1","key":"12544_CR24","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1186\/s12866-023-03136-w","volume":"23","author":"S Tao","year":"2023","unstructured":"Tao S, Hu C, Fang Y, Zhang H, Xu Y, Zheng L, Chen L, Liang W (2023) Targeted elimination of Vancomycin resistance gene vanA by CRISPR-Cas9 system. BMC Microbiol 23(1):380. https:\/\/doi.org\/10.1186\/s12866-023-03136-w","journal-title":"BMC Microbiol"},{"issue":"2","key":"12544_CR25","doi-asserted-by":"publisher","first-page":"e10381","DOI":"10.1002\/btm2.10381","volume":"8","author":"K Khambhati","year":"2022","unstructured":"Khambhati K, Bhattacharjee G, Gohil N, Dhanoa GK, Sagona AP, Mani I, Bui NL, Chu DT, Karapurkar JK, Jang SH, Chung HY, Maurya R, Alzahrani KJ, Ramakrishna S, Singh V (2022) Phage engineering and phage-assisted CRISPR-Cas delivery to combat multidrug-resistant pathogens. Bioeng translational Med 8(2):e10381. https:\/\/doi.org\/10.1002\/btm2.10381","journal-title":"Bioeng translational Med"},{"issue":"3","key":"12544_CR26","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3390\/pharmaceutics13030352","volume":"13","author":"F Wan","year":"2021","unstructured":"Wan F, Draz MS, Gu M, Yu W, Ruan Z, Luo Q (2021) Novel Strategy to Combat Antibiotic Resistance: A Sight into the Combination of CRISPR\/Cas9 and Nanoparticles. Pharmaceutics 13(3):352. https:\/\/doi.org\/10.3390\/pharmaceutics13030352","journal-title":"Pharmaceutics"},{"key":"12544_CR27","doi-asserted-by":"publisher","first-page":"5229","DOI":"10.2147\/IDR.S494327","volume":"17","author":"MM Ahmed","year":"2024","unstructured":"Ahmed MM, Kayode HH, Okesanya OJ, Ukoaka BM, Eshun G, Mourid MR, Adigun OA, Ogaya JB, Mohamed ZO, Lucero-Prisno DE 3rd (2024) CRISPR-Cas Systems in the Fight Against Antimicrobial Resistance: Current Status, Potentials, and Future Directions. Infect drug Resist 17:5229\u20135245. https:\/\/doi.org\/10.2147\/IDR.S494327","journal-title":"Infect drug Resist"},{"issue":"3","key":"12544_CR28","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1128\/MMBR.00069-15","volume":"80","author":"DP Pires","year":"2016","unstructured":"Pires DP, Cleto S, Sillankorva S, Azeredo J, Lu TK (2016) Genetically Engineered Phages: a Review of Advances over the Last Decade. Microbiol Mol biology reviews: MMBR 80(3):523\u2013543. https:\/\/doi.org\/10.1128\/MMBR.00069-15","journal-title":"Microbiol Mol biology reviews: MMBR"},{"key":"12544_CR29","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/978-1-60327-164-6_13","volume":"501","author":"HW Ackermann","year":"2009","unstructured":"Ackermann HW (2009) Phage classification and characterization. Methods Mol biology (Clifton N J) 501:127\u2013140. https:\/\/doi.org\/10.1007\/978-1-60327-164-6_13","journal-title":"Methods Mol biology (Clifton N J)"},{"issue":"9","key":"12544_CR30","doi-asserted-by":"publisher","first-page":"4243","DOI":"10.1093\/nar\/gkw223","volume":"44","author":"L Cui","year":"2016","unstructured":"Cui L, Bikard D (2016) Consequences of Cas9 cleavage in the chromosome of Escherichia coli. Nucleic Acids Res 44(9):4243\u20134251. https:\/\/doi.org\/10.1093\/nar\/gkw223","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"12544_CR31","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1093\/jac\/dkz246","volume":"74","author":"P Wang","year":"2019","unstructured":"Wang P, He D, Li B, Guo Y, Wang W, Luo X, Zhao X, Wang X (2019) Eliminating mcr-1-harbouring plasmids in clinical isolates using the CRISPR\/Cas9 system. J Antimicrob Chemother 74(9):2559\u20132565. https:\/\/doi.org\/10.1093\/jac\/dkz246","journal-title":"J Antimicrob Chemother"},{"key":"12544_CR32","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.2147\/IDR.S244885","volume":"13","author":"P Wan","year":"2020","unstructured":"Wan P, Cui S, Ma Z, Chen L, Li X, Zhao R, Xiong W, Zeng Z (2020) Reversal of mcr-1-Mediated Colistin Resistance in Escherichia coli by CRISPR-Cas9 System. Infect drug Resist 13:1171\u20131178. https:\/\/doi.org\/10.2147\/IDR.S244885","journal-title":"Infect drug Resist"},{"issue":"17","key":"12544_CR33","doi-asserted-by":"publisher","first-page":"e00534","DOI":"10.1128\/JVI.00534-18","volume":"92","author":"J Shen","year":"2018","unstructured":"Shen J, Zhou J, Chen GQ, Xiu ZL (2018) Efficient Genome Engineering of a Virulent Klebsiella Bacteriophage Using CRISPR-Cas9. J Virol 92(17):e00534\u2013e00518. https:\/\/doi.org\/10.1128\/JVI.00534-18","journal-title":"J Virol"},{"issue":"23","key":"12544_CR34","doi-asserted-by":"publisher","first-page":"e01834","DOI":"10.1128\/AEM.01834-18","volume":"84","author":"Y Wang","year":"2018","unstructured":"Wang Y, Wang S, Chen W, Song L, Zhang Y, Shen Z, Yu F, Li M, Ji Q (2018) CRISPR-Cas9 and CRISPR-Assisted Cytidine Deaminase Enable Precise and Efficient Genome Editing in Klebsiella pneumoniae. Appl Environ Microbiol 84(23):e01834\u2013e01818. https:\/\/doi.org\/10.1128\/AEM.01834-18","journal-title":"Appl Environ Microbiol"},{"issue":"9","key":"12544_CR35","doi-asserted-by":"publisher","first-page":"e00843","DOI":"10.1128\/AAC.00843-20","volume":"64","author":"M Hao","year":"2020","unstructured":"Hao M, He Y, Zhang H, Liao XP, Liu YH, Sun J, Du H, Kreiswirth BN, Chen L (2020) CRISPR-Cas9-Mediated Carbapenemase Gene and Plasmid Curing in Carbapenem-Resistant Enterobacteriaceae. Antimicrob Agents Chemother 64(9):e00843\u2013e00820. https:\/\/doi.org\/10.1128\/AAC.00843-20","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"12544_CR36","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3390\/pathogens9050385","volume":"9","author":"R Miggiano","year":"2020","unstructured":"Miggiano R, Rizzi M, Ferraris DM (2020) Mycobacterium tuberculosis Pathogenesis, Infection Prevention and Treatment. Pathogens (Basel Switzerland) 9(5):385. https:\/\/doi.org\/10.3390\/pathogens9050385","journal-title":"Pathogens (Basel Switzerland)"},{"issue":"3","key":"12544_CR37","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nbt.2508","volume":"31","author":"W Jiang","year":"2013","unstructured":"Jiang W, Bikard D, Cox D, Zhang F, Marraffini LA (2013) RNA-guided editing of bacterial genomes using CRISPR-Cas systems. Nat Biotechnol 31(3):233\u2013239. https:\/\/doi.org\/10.1038\/nbt.2508","journal-title":"Nat Biotechnol"},{"issue":"5","key":"12544_CR38","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/s41591-019-0437-z","volume":"25","author":"RM Dedrick","year":"2019","unstructured":"Dedrick RM, Guerrero-Bustamante CA, Garlena RA, Russell DA, Ford K, Harris K, Gilmour KC, Soothill J, Jacobs-Sera D, Schooley RT, Hatfull GF, Spencer H (2019) Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus. Nat Med 25(5):730\u2013733. https:\/\/doi.org\/10.1038\/s41591-019-0437-z","journal-title":"Nat Med"},{"issue":"4","key":"12544_CR39","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1051\/jbio\/2018004","volume":"211","author":"D Bikard","year":"2017","unstructured":"Bikard D, Barrangou R (2017) Les syst\u00e8mes CRISPR-Cas comme arme contre les bact\u00e9ries pathog\u00e8nes [CRISPR-Cas systems as weapons against pathogenic bacteria]. Biol aujourd\u2019hui 211(4):265\u2013270. https:\/\/doi.org\/10.1051\/jbio\/2018004","journal-title":"Biol aujourd\u2019hui"},{"issue":"10325","key":"12544_CR40","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"Antimicrobial Resistance Collaborators","year":"2022","unstructured":"Antimicrobial Resistance Collaborators (2022) Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet (London England) 399(10325):629\u2013655. https:\/\/doi.org\/10.1016\/S0140-6736(21)02724-0","journal-title":"Lancet (London England)"},{"issue":"5","key":"12544_CR41","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41579-022-00820-y","volume":"21","author":"EM Darby","year":"2023","unstructured":"Darby EM, Trampari E, Siasat P, Gaya MS, Alav I, Webber MA, Blair JMA (2023) Molecular mechanisms of antibiotic resistance revisited. Nat Rev Microbiol 21(5):280\u2013295. https:\/\/doi.org\/10.1038\/s41579-022-00820-y","journal-title":"Nat Rev Microbiol"},{"key":"12544_CR42","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2147\/VMRR.S366533","volume":"13","author":"YA Getahun","year":"2022","unstructured":"Getahun YA, Ali DA, Taye BW, Alemayehu YA (2022) Multidrug-Resistant Microbial Therapy Using Antimicrobial Peptides and the CRISPR\/Cas9 System. Veterinary Med (Auckland N Z) 13:173\u2013190. https:\/\/doi.org\/10.2147\/VMRR.S366533","journal-title":"Veterinary Med (Auckland N Z)"},{"key":"12544_CR43","doi-asserted-by":"publisher","first-page":"964848","DOI":"10.3389\/fmicb.2022.964848","volume":"13","author":"S Ghosh","year":"2022","unstructured":"Ghosh S, Lahiri D, Nag M, Sarkar T, Pati S, Edinur HA, Kumar M, Mohd Zain MRA, Ray RR (2022) Precision targeting of food biofilm-forming genes by microbial scissors: CRISPR-Cas as an effective modulator. Front Microbiol 13:964848. https:\/\/doi.org\/10.3389\/fmicb.2022.964848","journal-title":"Front Microbiol"},{"issue":"4","key":"12544_CR44","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1089\/phage.2024.0011","volume":"5","author":"M Rahimian","year":"2024","unstructured":"Rahimian M, Jafari-Gharabaghlou D, Mohammadi E, Zarghami N (2024) A New Insight into Phage Combination Therapeutic Approaches Against Drug-Resistant Mixed Bacterial Infections. PHAGE (New Rochelle N Y) 5(4):203\u2013222. https:\/\/doi.org\/10.1089\/phage.2024.0011","journal-title":"PHAGE (New Rochelle N Y)"},{"issue":"2","key":"12544_CR45","doi-asserted-by":"publisher","first-page":"e00066","DOI":"10.1128\/CMR.00066-18","volume":"32","author":"FL Gordillo Altamirano","year":"2019","unstructured":"Gordillo Altamirano FL, Barr JJ (2019) Phage Therapy in the Postantibiotic Era. Clin Microbiol Rev 32(2):e00066\u2013e00018. https:\/\/doi.org\/10.1128\/CMR.00066-18","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"12544_CR46","doi-asserted-by":"publisher","first-page":"3197","DOI":"10.1038\/s41467-024-47416-z","volume":"15","author":"N Quinones-Olvera","year":"2024","unstructured":"Quinones-Olvera N, Owen SV, McCully LM, Marin MG, Rand EA, Fan AC, Dosumu M, Paul OJ, Sanchez K, Casta\u00f1o CE, Petherbridge R, Paull JS, Baym M (2024) Diverse and abundant phages exploit conjugative plasmids. Nat Commun 15(1):3197. https:\/\/doi.org\/10.1038\/s41467-024-47416-z","journal-title":"Nat Commun"},{"key":"12544_CR47","doi-asserted-by":"publisher","first-page":"27128","DOI":"10.1038\/srep27128","volume":"6","author":"ON Silva","year":"2016","unstructured":"Silva ON, Alves ES, de la Fuente-N\u00fa\u00f1ez C, Ribeiro SM, Mandal SM, Gaspar D, Veiga AS, Castanho MA, Andrade CA, Nascimento JM, Fensterseifer IC, Porto WF, Correa JR, Hancock RE, Korpole S, Oliveira AL, Liao LM, Franco OL (2016) Structural Studies of a Lipid-Binding Peptide from Tunicate Hemocytes with Anti-Biofilm Activity. Sci Rep 6:27128. https:\/\/doi.org\/10.1038\/srep27128","journal-title":"Sci Rep"},{"issue":"11","key":"12544_CR48","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.3390\/pharmaceutics14112533","volume":"14","author":"M Akbarian","year":"2022","unstructured":"Akbarian M, Chen SH (2022) Instability Challenges and Stabilization Strategies of Pharmaceutical Proteins. Pharmaceutics 14(11):2533. https:\/\/doi.org\/10.3390\/pharmaceutics14112533","journal-title":"Pharmaceutics"},{"issue":"6","key":"12544_CR49","doi-asserted-by":"publisher","first-page":"1902312","DOI":"10.1002\/advs.201902312","volume":"7","author":"H Manghwar","year":"2020","unstructured":"Manghwar H, Li B, Ding X, Hussain A, Lindsey K, Zhang X, Jin S (2020) CRISPR\/Cas Systems in Genome Editing: Methodologies and Tools for sgRNA Design, Off-Target Evaluation, and Strategies to Mitigate Off-Target Effects. Adv Sci (Weinheim Baden-Wurttemberg Germany) 7(6):1902312. https:\/\/doi.org\/10.1002\/advs.201902312","journal-title":"Adv Sci (Weinheim Baden-Wurttemberg Germany)"},{"key":"12544_CR50","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.2147\/IJN.S453566","volume":"19","author":"KS Allemailem","year":"2024","unstructured":"Allemailem KS (2024) Recent Advances in Understanding the Molecular Mechanisms of Multidrug Resistance and Novel Approaches of CRISPR\/Cas9-Based Genome-Editing to Combat This Health Emergency. Int J Nanomed 19:1125\u20131143. https:\/\/doi.org\/10.2147\/IJN.S453566","journal-title":"Int J Nanomed"},{"issue":"1","key":"12544_CR51","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1038\/s41467-023-37789-y","volume":"14","author":"R Wang","year":"2023","unstructured":"Wang R, Shu X, Zhao H, Xue Q, Liu C, Wu A, Cheng F, Wang L, Zhang Y, Feng J, Wu N, Li M (2023) Associate toxin-antitoxin with CRISPR-Cas to kill multidrug-resistant pathogens. Nat Commun 14(1):2078. https:\/\/doi.org\/10.1038\/s41467-023-37789-y","journal-title":"Nat Commun"},{"issue":"6","key":"12544_CR52","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.3390\/antibiotics12061075","volume":"12","author":"MU Javed","year":"2023","unstructured":"Javed MU, Hayat MT, Mukhtar H, Imre K (2023) CRISPR-Cas9 System: A Prospective Pathway toward Combatting Antibiotic Resistance. Antibiot (Basel Switzerland) 12(6):1075. https:\/\/doi.org\/10.3390\/antibiotics12061075","journal-title":"Antibiot (Basel Switzerland)"},{"key":"12544_CR53","doi-asserted-by":"publisher","first-page":"113122","DOI":"10.1016\/j.biopha.2022.113122","volume":"151","author":"A Nath","year":"2022","unstructured":"Nath A, Bhattacharjee R, Nandi A, Sinha A, Kar S, Manoharan N, Mitra S, Mojumdar A, Panda PK, Patro S, Dutt A, Ahuja R, Verma SK, Suar M (2022) Phage delivered CRISPR-Cas system to combat multidrug-resistant pathogens in gut microbiome. Biomed pharmacotherapy = Biomedecine pharmacotherapie 151:113122. https:\/\/doi.org\/10.1016\/j.biopha.2022.113122","journal-title":"Biomed pharmacotherapy = Biomedecine pharmacotherapie"},{"issue":"1","key":"12544_CR54","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1186\/s12951-024-02576-4","volume":"22","author":"H Wang","year":"2024","unstructured":"Wang H, Yang Y, Xu Y, Chen Y, Zhang W, Liu T, Chen G, Wang K (2024) Phage-based delivery systems: engineering, applications, and challenges in nanomedicines. J Nanobiotechnol 22(1):365. https:\/\/doi.org\/10.1186\/s12951-024-02576-4","journal-title":"J Nanobiotechnol"},{"key":"12544_CR55","doi-asserted-by":"publisher","first-page":"1747931","DOI":"10.3389\/fmicb.2026.1747931","volume":"17","author":"MSI Wizrah","year":"2026","unstructured":"Wizrah MSI (2026) CRISPR-Cas systems as next-generation antimicrobials: a systemic review of mechanisms, delivery strategies, and translational challenges. Front Microbiol 17:1747931. https:\/\/doi.org\/10.3389\/fmicb.2026.1747931","journal-title":"Front Microbiol"},{"issue":"2","key":"12544_CR56","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1021\/acsnano.8b06395","volume":"13","author":"H Peng","year":"2019","unstructured":"Peng H, Chen IA (2019) Rapid Colorimetric Detection of Bacterial Species through the Capture of Gold Nanoparticles by Chimeric Phages. ACS Nano 13(2):1244\u20131252. https:\/\/doi.org\/10.1021\/acsnano.8b06395","journal-title":"ACS Nano"},{"issue":"5","key":"12544_CR57","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1021\/acssensors.0c00654","volume":"5","author":"H Peng","year":"2020","unstructured":"Peng H, Borg RE, Nguyen ABN, Chen IA (2020) Chimeric Phage Nanoparticles for Rapid Characterization of Bacterial Pathogens: Detection in Complex Biological Samples and Determination of Antibiotic Sensitivity. ACS Sens 5(5):1491\u20131499. https:\/\/doi.org\/10.1021\/acssensors.0c00654","journal-title":"ACS Sens"},{"issue":"2","key":"12544_CR58","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1021\/acs.chemrev.4c00681","volume":"125","author":"H Peng","year":"2025","unstructured":"Peng H, Chen IA, Qimron U (2025) Engineering Phages to Fight Multidrug-Resistant Bacteria. Chem Rev 125(2):933\u2013971. https:\/\/doi.org\/10.1021\/acs.chemrev.4c00681","journal-title":"Chem Rev"},{"issue":"4","key":"12544_CR59","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1073\/pnas.1913234117","volume":"117","author":"H Peng","year":"2020","unstructured":"Peng H, Borg RE, Dow LP, Pruitt BL, Chen IA (2020) Controlled phage therapy by photothermal ablation of specific bacterial species using gold nanorods targeted by chimeric phages. Proc Natl Acad Sci USA 117(4):1951\u20131961. https:\/\/doi.org\/10.1073\/pnas.1913234117","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"12544_CR60","doi-asserted-by":"publisher","first-page":"4756","DOI":"10.1021\/acsnano.2c00048","volume":"16","author":"H Peng","year":"2022","unstructured":"Peng H, Rossetto D, Mansy SS, Jordan MC, Roos KP, Chen IA (2022) Treatment of Wound Infections in a Mouse Model Using Zn2+-Releasing Phage Bound to Gold Nanorods. ACS Nano 16(3):4756\u20134774. https:\/\/doi.org\/10.1021\/acsnano.2c00048","journal-title":"ACS Nano"},{"issue":"6","key":"12544_CR61","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.1021\/acsbiomaterials.4c02190","volume":"11","author":"H Peng","year":"2025","unstructured":"Peng H, Vexler S, Xu S, Chen IA (2025) Real-Time in Vivo Bacterial Imaging by Computed Tomography and Fluorescence Using Phage-Gold Nanorod Bioconjugates as Contrast Agents. ACS biomaterials Sci Eng 11(6):3297\u20133306. https:\/\/doi.org\/10.1021\/acsbiomaterials.4c02190","journal-title":"ACS biomaterials Sci Eng"},{"issue":"14","key":"12544_CR62","doi-asserted-by":"publisher","first-page":"4841","DOI":"10.1128\/AEM.00812-15","volume":"81","author":"J Colom","year":"2015","unstructured":"Colom J, Cano-Sarabia M, Otero J, Cort\u00e9s P, Maspoch D, Llagostera M (2015) Liposome-Encapsulated Bacteriophages for Enhanced Oral Phage Therapy against Salmonella spp. Appl Environ Microbiol 81(14):4841\u20134849. https:\/\/doi.org\/10.1128\/AEM.00812-15","journal-title":"Appl Environ Microbiol"},{"issue":"5569","key":"12544_CR63","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1126\/science.1068054","volume":"296","author":"SW Lee","year":"2002","unstructured":"Lee SW, Mao C, Flynn CE, Belcher AM (2002) Ordering of quantum dots using genetically engineered viruses. Sci (New York N Y) 296(5569):892\u2013895. https:\/\/doi.org\/10.1126\/science.1068054","journal-title":"Sci (New York N Y)"},{"issue":"9","key":"12544_CR64","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.3390\/pharmaceutics14091936","volume":"14","author":"M Wdowiak","year":"2022","unstructured":"Wdowiak M, Paczesny J, Raza S (2022) Enhancing the Stability of Bacteriophages Using Physical, Chemical, and Nano-Based Approaches: A Review. Pharmaceutics 14(9):1936. https:\/\/doi.org\/10.3390\/pharmaceutics14091936","journal-title":"Pharmaceutics"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12544-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12544-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12544-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T11:42:04Z","timestamp":1786707724000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12544-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12544"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12544-w","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]},"assertion":[{"value":"12 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors report that there are no conflicts of interest in this work","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was not required for this study.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article contains no studies involving human or animal subjects.","order":4,"name":"Ethics","label":"Statement of human and animal rights","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There are no human subjects in this article, and informed consent is not applicable.","order":5,"name":"Ethics","label":"Statement of informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have read and agreed to the final version of the manuscript.","order":6,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1408"}}